News

A nephrology unit at Detroit-based Henry Ford Hospital has lowered Clostridioides difficile infections by 90% since 2023. Leaders at the hospital credit the progress to the Comprehensive Unit-based ...
Currently, C. difficile is first treated with antibiotics like vancomycin, against which the bacteria has not developed a ...
AI guidance for clinicians aimed at reducing the spread of Clostridioides difficile—a bacteria that can be deadly for sick ...
A new comparative study led by researchers at the UNC School of Medicine found that a new therapy for prevention of recurrent ...
Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label ...
Caffeic acid phenethyl ester treats Clostridioides difficile infection by neutralizing Clostridioides difficile toxin B and altering the gut microbiota and metabolites.
These drugs wipe out a wide range of gut flora making room for C. difficile to flourish [10]. Healthcare providers consider PMC when a patient on antibiotics develops sudden or worsening diarrhea ...
Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...
Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a ... doses of the shot compared to placebo in the 17,500-patient trial, which enrolled subjects 50 years of age and ...
Nurses and nurse midwives have historically considered patient education one of their most important responsibilities. Increasingly, however, appropriate and comprehensive patient education has ...
Healthcare innovation greatly benefits from the proactive inclusion of patients. Here we outline the importance of patients as co-creators of healthcare technology, providing insight into patient ...
IIT Kanpur has released the JEE Advanced 2025 response sheets on its official website, jeeadv.ac.in. Candidates can now download their individual response sheets to review their answers.